HCPCS Code J1411

Injection, etranacogene dezaparvovec-drlb, per therapeutic dose
Code effective Apr 01, 2023

HCPCS Section
Drugs administered other than oral method, chemotherapy drugs

J1411 is a valid 2026 HCPCS code meaning Injection, etranacogene dezaparvovec-drlb, per therapeutic dose or (Inj, hemgenix, per tx dose) for short. HCPCS J1411 has been effective since 04/01/2023 and applies to Medical care.

HCPCS Code Details - J1411

HCPCS Level II Code
Section J - Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J1411
Description

Long description:
Injection, etranacogene dezaparvovec-drlb, per therapeutic dose

Short description:
Inj, hemgenix, per tx dose

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Apr 01, 2023
Date added Added Apr 01, 2023

See also

  • HCPCS J1410 · Injection, estrogen conjugated, per 25 mg

  • HCPCS J1412 · Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.